ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinomaDeng-Shuang Wu(Qingdao University), Linhui Wang(Second Military Medical University)Journal of Experimental & Clinical Cancer ResearchJuly 4, 201610.1186/s13046-016-0383-2Cited by 52SaveCiteExport RISWatch citationsRelated PapersEfficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial|American Journal of Hematology|2025|5Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial|Blood|2023|2